Immunoprecipitation Market Size To Reach $1.1 Billion By 2030

Immunoprecipitation Market Growth & Trends

The global immunoprecipitation market size is anticipated to reach USD 1.1 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 5.7% from 2024 to 2030. Growth of the life science sector is expected to drive the market. Technological advancements in immunoprecipitation techniques is another factor contributing to high demand.

Immunoprecipitation helps precipitate target protein from a solution by binding an antibody to that protein. This technique allows isolation and concentration of a particular protein or protein complex out of a sample of numerous different proteins. Growth in the life science industry is rising mainly due to significant investments made in the R&D sector by key players. In 2016, Merck invested around USD 286.8 million in R&D, which supported their launch of over 2,000 products.

Introduction of novel products in protein purification methods has led to rapid growth in the market. For instance, in 2016, Thermo Fisher Scientific introduced a new antibody testing and verification methodology by using Immunoprecipitation-Mass Spectrometry technique. This is developed in order to assist antibody manufacturers, researchers, and other customers in identifying a suitable antibody for protein analysis. Availability of varied kits and reagents, such as antibodies, beads, and buffers is expected to increase the adoption of this technique to a great extent.

 Request a free sample copy or view report summary: Immunoprecipitation Market Report

Immunoprecipitation Market Report Highlights

• The reagents product segment dominated the immunoprecipitation market with a revenue share of 53.9% in 2023. The reagents segment is dominated by antibodies, which are used extensively for various immunoprecipitation techniques.

• The individual protein immunoprecipitation type segment dominated the immunoprecipitation market with a revenue share of 28.6% in 2023.

• The academic & research institutes segment dominated the immunoprecipitation market with a revenue share of 45.1% in 2023, fueled by increased R&D investments and funding from government grants, donations, and private organizations.

• North America immunoprecipitation market dominated the global immunoprecipitation market with a revenue share of 36.7% in 2023.

Immunoprecipitation Market Segmentation

Grand View Research has segmented the global immunoprecipitation market on the basis of product, type, end-use, and region:

Immunoprecipitation Product Outlook (Revenue, USD Million, 2018 - 2030)

• Kits

• Reagents

  • Antibodies

  • Beads

  • Others

Immunoprecipitation Type Outlook (Revenue, USD Million, 2018 - 2030)

• Individual Protein Immunoprecipitation

• Protein Complex Immunoprecipitation

• Chromatin Immunoprecipitation

• Ribonucleoprotein Immunoprecipitation

• Tagged Proteins Immunoprecipitation

Immunoprecipitation End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Academic & Research Institutes

• Pharmaceutical & Biotechnology Companies

• Contract Research Organizations

Immunoprecipitation Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Immunoprecipitation Market

• Thermo Fisher Scientific Inc.

• Abcam Limited

• BioLegend, Inc.

• Bio-Rad Laboratories, Inc.

• GenScript

• Merck KGaA

• Novus Biologicals

• Takara Bio Inc.

• Biologics International Corp